CMIC Group: Japan’s first and largest CRO continues 30-year evolution to help global sponsors navigate the complex local market
Japan’s clinical trial landscape has vastly expanded over the last 30 years and CMIC has been at the forefront of the country’s evolution in drug development.
In an interview with Endpoints News publisher and founder Arsalan Arif, CMIC’s CEO and founder, Kazuo Nakamura, and COO, Keiko Oishi, both share their insights into CMIC Group’s unique story, while outlining their vision for the future.
